Comparison of capillary based microflurometric assay for CD4+ T cell count estimation with dual platform flow cytometry

被引:12
作者
Thakar M.R. [1 ]
Kumar B.K. [1 ]
Mahajan B.A. [1 ]
Mehendale S.M. [1 ]
Paranjape R.S. [1 ]
机构
[1] National AIDS Research Institute, Bhosari
关键词
Absolute Lymphocyte Count; Single Platform; High Event Rate; Sheath Fluid; Agreeable Limit;
D O I
10.1186/1742-6405-3-26
中图分类号
学科分类号
摘要
The CD4+ T cell count estimation is an important monitoring tool for HIV disease progression and efficacy of anti-retroviral treatment (ART). Due to availability of ART at low cost in developing countries, quest for reliable cost effective alternative methods for CD4+ T cell count estimation has gained importance. A simple capillary-based microflurometric assay (EasyCD4 System, Guava Technology) was compared with the conventional flow cytometric assay for estimation of CD4+ T cell counts in 79 HIV infected individuals. CD4+ T cell count estimation by both the assays showed strong correlation (r = 0.938, p < 0.001, 95% Cl 0.90 to 0.96). The Bland Altman plot analysis showed that the limits of variation were within agreeable limits of ± 2SD (-161 to 129 cells/ mm3). The Easy CD4 assay showed 100% sensitivity for estimating the CD4+ T cell counts < 200 cells/mm3 and < 350 cells/mm3 and 97% sensitivity to estimate CD4+ T cell count < 500 cells/mm3. The specificity ranged from 82 to 100%. The Kappa factor ranged from 0.735 for the CD4+ T cell counts < 350 cells/mm3 to 0.771 for < 500 cells/ mm3 CD4+ T cell counts. The system works with a simple protocol, is easy to maintain and has low running cost. The system is compact and generates minimum amount of waste. Hence the EasyCD4 System could be applied for estimation of CD4+ T cell counts in resource poor settings. © 2006 Thakar et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 18 条
[1]  
The WHO and UNAIDS global initiative to provide antiretroviral therapy to 3 million people with HIV/AIDS in developing countries by the end of 2005/Treat 3 Million by 2005, (2006)
[2]  
Kovacs J.A., Masur H., Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection, N Engl J Med, 342, pp. 1416-1429, (2003)
[3]  
Brando B., Barnett D., Janossy G., Mandy F., Autran B., Rothe G., Scarpati B., D'Avanzo G., D'Hautcourt J.L., Lenkei R., Schmitz G., Kunkl A., Chianese R., Papa S., Gratama J.W., Cytoflurimetric methods for assessing absolute numbers of cell subsets in blood, Cytometry, 42, pp. 327-346, (2000)
[4]  
Crowe S., Turnbull S., Oelrichs R., Monitoring of human immunodeficiency virus infection in resource-constrained countries, Clin Infect Dis, 37, SUPPL. I, (2003)
[5]  
Pattanapanyasat K., Thakar M.R., CD4+ T cell count as a tool to monitor HIV progression & anti-retroviral therapy, Indian J Med Res, 121, 4, pp. 539-549, (2005)
[6]  
Nicholson J.K., Velleca W.M., Jubert S., Green T., Bryan L., Evaluation of alternative CD4 technologies for the enumeration for CD4 lymphocytes, J Immunol Methods, 28, pp. 43-54, (1994)
[7]  
Carella A.V., Moss M.W., Provost V., Quinn T.C., A manual bead assay for the determination of absolute CD4 + and CD8 + lymphocyte counts in human immunodeficiency virus- infected individuals, Clin Diagn Lab Immunol, 2, 5, pp. 623-625, (1995)
[8]  
Didier J.M., Kazatchkine M.D., Demouchy C., Moat C., Diagbouga S., Sepulveda C., Di Lonardo A.M., Weiss L., Comparative assessment of five alternative methods for CD4+ T- lymphocyte enumeration for implementation in developing countries, J Acquir Immune Defic Syndr, 26, pp. 193-195, (2001)
[9]  
Landay A., Ho J., Hom D., Russell T., Zweener R., Minsty J., A rapid manual method for CD4+ T-cell quantitation for use in developing countries, AIDS, 7, 12, pp. 1565-1568, (1993)
[10]  
Rodriguez W., Mohanty M., Christodoulides N., Goodey A., Romanovicz D., Ali M., Floriano P., Walker B., McDevitt J., Development of affordable, portable CD4 counts for resource- poor settings using microchips (abstract 1751b), (2003)